Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials
- PMID: 39136311
- DOI: 10.1111/jce.16396
Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials
Abstract
Background: The prevalence and impact of obesity on outcomes of atrial fibrillation (AF) ablation randomized controlled trials (RCTs) have not been well studied.
Objective: To examine the proportion of participants with obesity enrolled in RCTs of AF ablation and outcomes of ablation when subgroup analysis of participants with obesity were available.
Methods: We systematically searched PubMed and EMBASE for AF ablation RCTs published between January 1, 2015 to May 31, 2022. When body mass index (BMI) data were available, normal distribution was assumed and a z score was used to estimate the proportion of obesity. Results categorized by BMI or body weight status were reviewed. Authors were contacted for additional information.
Results: Of 148 eligible RCTs with 30174 participants, 144 (97.30%) RCTs did not report the proportion of participants with obesity, while published information regarding BMI was available in 63.51%. Three trials excluded patients based on BMI. Using reported BMI, we estimated the proportion of participants with obesity varied greatly across these trials, ranging from 5.82%-71.9% (median 38.02%, interquartile 29.64%, 49.10%). Patients with obesity were represented in a greater proportion among trials conducted in North America (50.23%) and Asia (44.72%), compared to others (32.16%), p < .001. Subgroup analysis or analysis adjusting for BMI was reported in only 13 (8.78%) RCTs; four (30.77%) of these suggested that BMI or body weight might negatively affect primary outcomes.
Conclusion: Obesity is a common comorbidity among AF patients. However, most AF ablation RCTs underreported the proportion of participants with obesity and its impact on the primary outcomes.
Keywords: atrial fibrillation; body mass index; catheter ablation; obesity; randomized controlled trial.
© 2024 The Author(s). Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.
Similar articles
-
Representation of Women in Atrial Fibrillation Ablation Randomized Controlled Trials: Systematic Review.J Am Heart Assoc. 2025 Jan 21;14(2):e035181. doi: 10.1161/JAHA.124.035181. Epub 2025 Jan 10. J Am Heart Assoc. 2025. PMID: 39791402 Free PMC article.
-
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14. J Cardiovasc Electrophysiol. 2018. PMID: 29131442
-
Impact of obesity on atrial fibrillation ablation: Patient characteristics, long-term outcomes, and complications.Heart Rhythm. 2017 Jun;14(6):819-827. doi: 10.1016/j.hrthm.2017.02.023. Epub 2017 Feb 20. Heart Rhythm. 2017. PMID: 28232261
-
Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.J Cardiovasc Electrophysiol. 2008 Jul;19(7):668-72. doi: 10.1111/j.1540-8167.2008.01118.x. Epub 2008 Mar 21. J Cardiovasc Electrophysiol. 2008. PMID: 18363693 Clinical Trial.
-
Meta-analysis of medical management versus catheter ablation for atrial fibrillation.Rev Cardiovasc Med. 2020 Sep 30;21(3):419-432. doi: 10.31083/j.rcm.2020.03.60. Rev Cardiovasc Med. 2020. PMID: 33070546
Cited by
-
Obesity and Atrial Fibrillation: A Comprehensive Review.Methodist Debakey Cardiovasc J. 2025 Feb 18;21(2):35-43. doi: 10.14797/mdcvj.1516. eCollection 2025. Methodist Debakey Cardiovasc J. 2025. PMID: 39990752 Free PMC article. Review.
-
Cryoballoon Pulmonary Vein Isolation in Obese Patients with Atrial Fibrillation Compared to Non-Obese Counterparts: A Meta-Analysis.Biomedicines. 2025 Jan 25;13(2):298. doi: 10.3390/biomedicines13020298. Biomedicines. 2025. PMID: 40002711 Free PMC article. Review.
References
REFERENCES
-
- Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013;112(8):1142‐1147.
-
- Middeldorp ME, Kamsani SH, Sanders P. Obesity and atrial fibrillation: prevalence, pathogenesis, and prognosis. Prog Cardiovasc Dis. 2023;78:34‐42.
-
- Xu H, Cupples LA, Stokes A, Liu CT. Association of obesity with mortality over 24 years of weight history: findings from the Framingham Heart Study. JAMA Netw Open. 2018;1(7):e184587.
-
- Wong CX, Sullivan T, Sun MT, et al. Obesity and the risk of incident, post‐operative, and post‐ablation atrial fibrillation: a meta‐analysis of 626,603 individuals in 51 studies. JACC Clin Electrophysiol. 2015;1(3):139‐152.
-
- Providencia R, Adragão P, deAsmundis C, et al. Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European Observational Multicenter study. J Am Heart Assoc. 2019;8(20):e012253.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical